MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS

被引：0
|
作者：
HUNT, BJ [1 ]
SEGAL, H [1 ]
YACOUB, M [1 ]
机构：
[1] HAREFIELD HOSP,HAREFIELD UB9 6TH,MIDDX,ENGLAND
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1025 / 1025
页数：1
相关论文
共 50 条
  • [1] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, HC
    YACOUB, M
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
  • [2] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    [J]. CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [3] MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME
    BERG, E
    STENBJERG, S
    ALBRECHTSEN, OK
    [J]. JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1979, 11 (06): : 229 - 235
  • [4] APROTININ AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    [J]. CIRCULATION, 1992, 86 (05) : 410 - 412
  • [5] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS IN MAN - USE OF FLUOROGENIC HEPARIN ASSAY TO VALIDATE ACTIVATED CLOTTING TIME
    HUGHES, DR
    FAUST, RJ
    DIDISHEIM, P
    TINKER, JH
    [J]. ANESTHESIA AND ANALGESIA, 1982, 61 (02): : 189 - 190
  • [6] LACK OF CORRELATION BETWEEN ACTIVATED CLOTTING TIME AND PLASMA HEPARIN DURING CARDIOPULMONARY BYPASS
    CULLIFORD, AT
    GITEL, SN
    STARR, N
    THOMAS, ST
    BAUMANN, FG
    WESSLER, S
    SPENCER, FC
    [J]. ANNALS OF SURGERY, 1981, 193 (01) : 105 - 111
  • [7] Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass
    Takashi Watanabe
    Kazuaki Shirota
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (6): : 530 - 530
  • [8] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [9] Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass
    Welsby I.J.
    McDonnell E.
    El-Moalem H.
    Stafford-Smith M.
    Toffaletti J.G.
    [J]. Journal of Clinical Monitoring and Computing, 2002, 17 (05) : 287 - 292
  • [10] Does low-dose aprotinin increase the activated clotting time (ACT) during cardiopulmonary bypass (CPB)
    Haddad, F
    Yazigi, A
    MadiJebara, S
    Hayek, G
    Antakly, MC
    [J]. ANESTHESIOLOGY, 1997, 87 (03) : A464 - A464
12345